Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsFuture challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSAMultidrug-resistant and methicillin-resistant Staphylococcus aureus (MRSA) in hog slaughter and processing plant workers and their community in North Carolina (USA)Staphylococcus aureus α-hemolysin mediates virulence in a murine model of severe pneumonia through activation of the NLRP3 inflammasomeHigh prevalence of abscesses and self-treatment among injection drug users in Tijuana, MexicoCommunity-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicEmergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skinDose of trimethoprim-sulfamethoxazole to treat skin and skin structure infections caused by methicillin-resistant Staphylococcus aureusCombating antimicrobial resistance: policy recommendations to save livesMolecular epidemiology of methicillin-resistant Staphylococcus aureus, rural southwestern AlaskaDalbavancin in the treatment of complicated skin and soft-tissue infections: a reviewGlobal distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infectionsIn vitro activities of the Rx-01 oxazolidinones against hospital and community pathogensPathogenesis of methicillin-resistant Staphylococcus aureus infectionProspective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureusEpidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolatesFocus on JNJ-Q2, a novel fluoroquinolone, for the management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infectionsThe Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine AntigensProfile of oritavancin and its potential in the treatment of acute bacterial skin structure infectionsCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciPotential role of tedizolid phosphate in the treatment of acute bacterial skin infectionsDevelopment of a vaccine against Staphylococcus aureusNeutrophils in innate host defense against Staphylococcus aureus infectionsClonal complex 398 methicillin susceptible Staphylococcus aureus: a frequent unspecialized human pathogen with specific phenotypic and genotypic characteristicsThe adherens junctions control susceptibility to Staphylococcus aureus α-toxinNeutrophil crawling in capillaries; a novel immune response to Staphylococcus aureusStructural Studies of Pterin-Based Inhibitors of Dihydropteroate SynthaseCrystal Structure of the 6-Hydroxymethyl-7,8-Dihydropterin Pyrophosphokinase•Dihydropteroate Synthase Bifunctional Enzyme from Francisella tularensisStructures of SdrD from Staphylococcus aureus reveal the molecular mechanism of how the cell surface receptors recognize their ligandsStructural enzymology and inhibition of the bi-functional folate pathway enzyme HPPK-DHPS from the biowarfare agent Francisella tularensisHost-pathogen interactions between the skin and Staphylococcus aureus.Pathogenesis of Staphylococcus aureus abscessesCommunity-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidinNorlichexanthone Reduces Virulence Gene Expression and Biofilm Formation in Staphylococcus aureusIncidence, microbiology, and patient characteristics of skin and soft-tissue infections in a U.S. population: a retrospective population-based studyPredicting observation unit treatment failures in patients with skin and soft tissue infectionsBacterial Etiology and Risk Factors Associated with Cellulitis and Purulent Skin Abscesses in Military TraineesAntimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.MRSA in conventional and alternative retail pork products
P2860
Q21131083-73BD6E3C-F325-42A3-B11F-D8C15EAF1CF8Q22305769-27674E1E-CDDD-47E7-9A5C-246023C62F77Q23920080-9BA5C039-F5A4-43AE-A4F3-C27F81809957Q24594277-A2AE38F8-64F1-4864-AC38-025F1E414F42Q24595189-4E03F285-38AA-41BA-80DF-0301D177E583Q24614464-DAA6E33F-9179-429E-BFD9-A42A723C966AQ24628799-987A3EE3-61C9-4281-86E3-92D7AB6C22A2Q24631182-F2FA3EA3-C89F-4FDB-B71B-812DD8AA6D9CQ24632857-5C77B2B0-CCF4-4502-8A89-2B9BF4EE262AQ24645571-75977252-EC77-40E1-BF32-1FFF58A07289Q24647429-91C3EB31-1BDE-4434-ADE1-CD6A2D5E5AD6Q24652423-110E3640-8EAE-4436-B38E-6F54EE32683DQ24652784-4162B00A-F7AB-44BD-8998-E92A109990FEQ24656140-69821087-E149-446C-9997-5720E4BBDC94Q24657579-19688E12-6C23-4B67-9B7A-BA0B4431176CQ24678579-A31C3363-0086-43B3-89D5-BB775DB2EA0EQ24684731-CFFE8789-C1BF-4EA6-A1B3-1C3C58DC5932Q26746197-63654009-54B6-447D-8FF0-DDAE99465C84Q26768436-25F1B815-4E72-4B9E-BEDE-8B5390945F41Q26799701-E5ABBA17-80A3-47D5-B2AA-9CF056141D75Q26853465-468818BC-94EE-4A00-9B41-ECEB99328CF5Q26853612-96528175-4DE6-4BFA-838D-BB7FACEFCF3CQ27015365-BB1EA41A-1084-48A9-82D6-CC846FE1F0C4Q27024628-1548ECA2-1E44-4092-A0C1-404A364AE3CCQ27311450-39EB69B7-9F5E-438B-B1C8-5DE218FF3A33Q27321037-AA40ED9A-0219-4CB2-9D2C-E8F0AC62E61CQ27324045-C5E50217-D238-4280-A5E7-382F14775A30Q27658109-AB8FC33C-212D-4AF5-94A8-EBFDAD3FC977Q27666288-83C747EF-772F-49EA-A284-F95467E58B68Q27677185-32889461-D326-4624-9122-D57B4ED85682Q27690820-1EEF1C2C-97C3-4926-B03E-599805AA631DQ27692552-71435AD4-11A6-4752-B3E3-BEDEBE4A87FBQ28080781-2F75D3D0-34C7-48B6-ADE2-6D3A2CD26C80Q28277284-87989A5E-F0CC-4C87-B7B5-D9F843E31964Q28354141-03EBF9EE-FA3D-48C5-81BC-B71AD37026A7Q28384260-13FCBDED-9D20-4BA1-8BE9-4D6BAB3971DFQ28387876-0B0322B3-A1FC-4EDC-9AAA-1FED4F617514Q28392520-E9957E89-C43C-43C3-9277-54BCB277DAA4Q28393128-A7DEB17F-6C13-45D6-A4A2-13FD97B363B7Q28395723-141722EA-EA71-4DE5-B662-8F5D26E7AE7D
P2860
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
description
im August 2006 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2006
@uk
name
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@en
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@nl
type
label
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@en
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@nl
prefLabel
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@en
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@nl
P2093
P356
P1476
Methicillin-ResistantS. aureusInfections among Patients in the Emergency Department
@en
P2093
Anusha Krishnadasan
David A. Talan
Gregory E. Fosheim
Gregory J. Moran
Linda K. McDougal
Rachel J. Gorwitz
Roberta B. Carey
P304
P356
10.1056/NEJMOA055356
P407
P577
2006-08-17T00:00:00Z